Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.04 USD
Change Today +0.07 / 1.76%
Volume 1.1M
ARNA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ARENA PHARMACEUTICALS INC (ARNA)

Arena Pharmaceuticals, Inc. to Report Q2, 2015 on Aug 05, 2015
CapIQ 08/05/2015 9:00 PM ET
Arena Pharmaceuticals, Inc. to Report Q1, 2015 on May 11, 2015
CapIQ 08/05/2015 9:00 PM ET
Arena Pharmaceuticals, Inc. to Report Q4, 2014 on Mar 02, 2015
CapIQ 08/05/2015 9:00 PM ET

2013 revenues at Arena Pharmaceuticals, Inc. totaled $81.4M USD, while annual losses equaled $0.09 per share.

Quarterly Earnings & Estimates - ARENA PHARMACEUTICALS INC (ARNA)

Actuals vs. Estimates for ARENA PHARMACEUTICALS INC ARNA

Arena Pharmaceuticals, Inc.'s Quarterly Earnings

Arena Pharmaceuticals, Inc. reported 2nd quarter 2014 losses of $0.12 per share on 08/3/2014.

Annual Earnings & Estimates - ARENA PHARMACEUTICALS INC (ARNA)

Actuals vs. Estimates for ARENA PHARMACEUTICALS INC ARNA

Arena Pharmaceuticals, Inc.'s Annual Earnings

Arena Pharmaceuticals, Inc. reported annual 2013 losses of $0.09 per share on 03/1/2014.

Quarterly Revenues - ARENA PHARMACEUTICALS INC (ARNA)

Actuals vs. Estimates for ARENA PHARMACEUTICALS INC ARNA

Arena Pharmaceuticals, Inc.'s Quarterly Revenues

Arena Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $12.8M USD. This bettered the $9.3M USD consensus of the 7 analysts covering the company. This was -81.4% below the prior year's 2nd quarter results.

Annual Revenues - ARENA PHARMACEUTICALS INC (ARNA)

Actuals vs. Estimates for ARENA PHARMACEUTICALS INC ARNA

Arena Pharmaceuticals, Inc.'s Annual Revenues

Arena Pharmaceuticals, Inc. had revenues for the full year 2013 of $81.4M USD. This was 195.0% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARNA:US $4.04 USD +0.07

ARNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ARIAD Pharmaceuticals Inc $8.16 USD +0.31
Array BioPharma Inc $5.81 USD +0.06
Orexigen Therapeutics Inc $4.00 USD +0.05
Progenics Pharmaceuticals Inc $8.66 USD +0.20
Rigel Pharmaceuticals Inc $2.98 USD +0.15
View Industry Companies
 

Industry Analysis

ARNA

Industry Average

Valuation ARNA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 22.5x
Price/Book 7.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.